Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease
A Multicenter, Randomized, Double Blind Study to Compare the Efficacy Between Cilostazol and Aspirin on White Matter Changes by Cerebral Small Vessel Disease
Sponsor: Inha University Hospital
Listed as NCT01932203, this PHASE4 trial focuses on Cerebral Small Vessel Disease and remains ongoing. Sponsored by Inha University Hospital, it has been updated 9 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE4
▶ Show 4 earlier versions
-
Sep 2019 — Jan 2021 [monthly]
Active Not Recruiting PHASE4
Status: Unknown Status → Active Not Recruiting
-
Nov 2018 — Sep 2019 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
First recorded
Jul 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Inha University Hospital
- Otsuka Pharmaceutical Development & Commercialization, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Anyang, South Korea
- • Bucheon-si, South Korea
- • Daejeon, South Korea
- • Goyang-si, South Korea
- • Gwangju, South Korea
- • Hwaseong-si, South Korea
- • Iksan, South Korea
- • Incheon, South Korea
- • Pusan, South Korea
- • Seoul, South Korea